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Abstract. Because environmental exposure to trauma is the sine qua non for the development of Post Traumatic Stress Disorder
(PTSD), the recent focus on genetic studies has been noteworthy. The main catalyst for such studies is the observation from
epidemiological studies that not all trauma survivors develop this disorder. Furthermore, neuroendocrine ﬁndings suggest pre-
existing hormonal alterations that confer risk for PTSD. This paper presents the rationale for examining genetic factors in PTSD
and trauma exposure, but suggests that studies of genotype may only present a limited picture of the molecular biology of this
disorder. We describe the type of information that can be obtained from candidate gene and genomic studies that incorporate
environmental factors in the design (i.e., gene – environment interaction and gene-environment correlation studies) and studies
that capitalize on the idea that environment modiﬁes gene expression, via epigenetic or other molecular mechanisms. The
examination of epigenetic mechanisms in tandem with gene expression will help reﬁne models that explain how PTSD risk,
pathophysiology, and recovery is mediated by the environment. Since inherited genetic variation may also inﬂuence the extent of
epigenetic or gene expression changes resulting from the environment, such studies should optimally be followed up by studies
of genotype.
1. If PTSD is a condition precipitated by
environmental exposure, why examine genes?
For at least two decades after the diagnosis of PTSD
was established in 1980, it would have been unheard
of to propose that genes might be involved in the eti-
ology or pathogenesis of this condition. PTSD was
initially deﬁned as a disorder that resulted from expo-
sure to a traumaticenvironmentalevent. The diagnosis
was designed to describe universal effects of extreme
stressthatlingerevenafterthestressorisremoved. The
theoretical contribution that this made to the biopsy-
chosocial model of mental illness was the realization
that the effects of an environmentalevent are not limit-
ed to initial exposure to the event, but can also persist
for years and even decades. These long-term effects
were conceptualized as being a function of the intensi-
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ty and severity of the event that precipitated the initial
symptoms.
The implication of the PTSD diagnosis was that the
adverse effects of exposure to chronic stressors (e.g.,
illness, family conﬂict, or ﬁnancial pressures) could
be alleviated or even eliminated if the challenge to the
person was removed (and hence were not precipitants
of PTSD). In contrast, the effects of exposure to life-
threatening events like interpersonal violence, combat,
andaccidentsthatcausedintensefear,helplessnessand
horror were not only persistent, but were of a specif-
ic and universal nature. The basic phenomenology of
PTSDassertedthatfollowingtraumaexposure,thesur-
vivor experiences unwanted, uncontrollable memories
of the event that generate physical and emotional re-
sponses resembling the fear responses that occur at the
time of exposure to the traumatic event. These memo-
ries result in avoidancebehaviorand hyperarousal,and
ultimately lead to social, occupational or interperson-
al dysfunction. Because exposure to fearful situations
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was thought to precipitate PTSD, the agenda for the
ﬁrst generationof neuroscience-basedstudies in PTSD
was to examine the neural, chemical, and hormonal
correlates of fear so as to better target the relevant bi-
ological systems involved in its pathophysiology. The
idea of identifyingtangibleevidenceof a lingeringdis-
turbanceinstress-relatedneurobiologywouldservenot
only to identify treatment targets, but also to validate
the existence of the PTSD diagnosis.
Thereweretwomajorobservationsinthe1990’sthat
changed the trajectory of biological studies in PTSD.
The ﬁrst observation came from a series of reports
showing that measures of cortisol and other aspects of
hypothalamic-pituitary-adrenal (HPA) axis regulation
in PTSD did not correspond to what would have been
predicted on the basis of stress theory. The most strik-
ing ﬁnding was that of lower cortisol in people with
PTSD, compared to those without PTSD [1]; (see [2]
for a review), which was unexpected because this hor-
moneis classicallythoughttobeelevatedinthecontext
of extreme stress and fear. At ﬁrst these ﬁndings were
considered paradoxical because they not only contra-
dicted the prediction that cortisol levels would be ele-
vated in a stress disorder, but also because they were
different than they would be in conditions that are fre-
quentlycomorbidwith PTSD, such as in major depres-
sive disorder. However, the second series of observa-
tions substantially clariﬁed the results from the hor-
monal studies, albeit indirectly. From epidemiologic
studies it becameclear that onlysome personsexposed
to trauma develop and maintain PTSD while others do
not [3–5].
The absence of PTSD in some trauma-exposed per-
sons challenged initial conceptions of PTSD as a nor-
mative response to extreme stress. This helped free
the ﬁeld from the tyranny of needing to hypothesize
that PTSD biology would be analogous to biological
alterations seen in response to stress and fear. The
observation from epidemiological studies that trauma
exposure alone does not fully determine either the de-
velopment of, or recovery from, PTSD provided the
justiﬁcation for evaluating pre-traumatic risk factors,
and for considering whether characteristics that differ-
entiatetraumasurvivorswithandwithoutPTSD reﬂect
riskforPTSD[6]. Whereaspreviouslyitwasimportant
to understand the biological changes that result from
exposureto environmentalevents, it was nowclearthat
such responses might have earlier antecedents that af-
fect such responses.
Together, then, biological and epidemiologicalstud-
iesalso clariﬁedthatPTSDdoesnotrepresentauniver-
sal response to a major environmentalevent, but rather
a speciﬁc phenotype, expressed in the presence of an
environmentalstressor, that is characterizedby a series
of biological events that do not permit, or in fact di-
rectly impair, reinstatement of physiologic homeosta-
sis or recovery from trauma [2,7]. If PTSD represents
a failure to recover from the normal effects of trauma,
then the pathophysiologyof PTSD might be explained
byindividualdifferencesin modulatorsof the response
to stress [8]. Delineating the contributions of such dif-
ferencesto the developmentof PTSD requires a broad-
er assessment of vulnerability than is currently prac-
ticed and will ideally include genotypic and molecular
factors, in addition to clinical and functional ones.
In this paper, we provide a justiﬁcation for examin-
ing molecular genetics and clarify current experimen-
tal approaches that can be used to identify genetic and
other molecular alterations in PTSD with the goal of
identifyingmechanismsthat explainPTSD risk, patho-
physiology, and recovery. Our purpose is to specify
the informationthat will be yielded by examininggene
x environment (GxE) interactions in PTSD versus ap-
proaches that will inform the enduring effects of envi-
ronment on genes. We describe the three major cate-
gories of molecular genetic studies of PTSD so as to
identify some of the complexities of considering genes
in the study of PTSD. Our intention is to emphasize
differencesbetweenstudies designedto examinegeno-
typeby environmentinteractionsin PTSD versusthose
that aim to elucidate how environmental experiences
such as trauma can produce PTSD, and examine the
implications for a molecular biology of PTSD.
2. Genetic vulnerability associated with PTSD
The idea that the presence of a speciﬁc gene vari-
ant (allele) could contribute to individual differences
in response to a traumatic event has been embraced by
the mental health community, even though this idea is
fairly radical in the contextof a disorderthat is thought
tobe broughtonbyexposureto anextremelytraumatic
event. This may, in part, be related to compelling evi-
dence from twin studies that genetic factors contribute
to the risk for PTSD (e.g [9–11] see [12] for review).
This was ﬁrst demonstrated in a cohort of combat vet-
erans [13],in which the risk for developingPTSD after
trauma exposure was signiﬁcantly greater for monozy-
gotic (non-combat exposed co-twin) than for dizygot-
ic twins of PTSD-affected probands. In a population-
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likelyto be concordantinmonozygotictwins, but there
was also a genetic association with exposure to vio-
lence (but not accidents or disaster). It was conclud-
ed that the genetic risk for assault trauma could reﬂect
personality traits – anger or irritability – that increased
the likelihood for assault.
Below we reviewseveralapproachesto identifyinga
genetic basis for PTSD while noting that at the writing
of this review few genes have been linked with PTSD.
The paucity of genetic studies in PTSD may reﬂect the
complexityinvolvedinexecutingresearchthatwillpro-
vide unambiguous results. That underlying genotypic
vulnerabilityforPTSDcanonlybeexpressedfollowing
trauma exposurelimits the practicality of family-based
linkage approaches. Sources of heterogeneity owing
to type of exposure presents a dilemma concerning
whethertofocusonPTSD froma widerangeofevents,
whichmaythemselvesinvolvegeneticriskfactors[10],
or to limit investigations to a particular subgroup with
common exposure (e.g., veterans). In considering the
appropriate “case-controls” for subjects with PTSD, it
is not clear whether to match comparison subjects on
the basis of exposuretype or other factors such as race,
whichmayalsoconstituteriskfactorsand,ifcontrolled
for,mayobscureothergeneticassociations. Theneces-
sity of actively recruiting subjects with PTSD without
regard for whether they are representative of the nor-
mal population presents a problem of determining the
variables on which to match comparison subjects. For
example, comparison subjects may possess the genetic
vulnerabilityforPTSDbutlackexposuretoatraumatic
event. Without the ability to examine different levels
of trauma exposure from within the context of a com-
mon random event affecting an entire population and
resulting in different outcomes with respect to PTSD,
it is not feasible within the conﬁnes of a single study to
generate interpretable data.
3. Gene association studies in PTSD
One way to determine whether genes are involved
in PTSD risk or pathophysiology is to identify allelic
variants of genes that might be associated with PTSD.
This can be done by examining speciﬁc genes that are
hypothesized to represent the origin of a more down-
stream, observed biological alteration. Alternatively,
gene variants can be identiﬁed by examining [nearly]
the entire genome simultaneously. Candidate gene as-
sociationstudiesrepresenttheapproachmostcommon-
ly used in the ﬁeld of PTSD genetics thus far. Such
studies examine genotype variations at speciﬁc loci on
a gene or genes and compare genotype or allelic fre-
quencies between people who do versus do not devel-
op PTSD in a group of similarly exposed trauma sur-
vivors. The alleles (i.e., alternative forms of genetic
variation–orpolymorphisms–at aspeciﬁclocus)usu-
ally take one of two forms: single nucleotide polymor-
phisms (SNPs), in which the genetic variation occurs
at the nucleotide(base pair) level; and variable number
of tandem repeats (VNTRs), in which the genetic vari-
ationoccursin the numberofrepetitivesequences(i.e.,
a length polymorphism).
Themostcompellingreasonforusingacandidateap-
proach is that this is a hypothesis testing approach that
bases the selection of speciﬁc genes on known biolog-
ical and psychological correlates of PTSD and PTSD
risk obtained from prior research on aspects of the bi-
ological response to stress, or to biological processes
thatunderlieindividualdifferencesinstressvulnerabil-
ity. For this reason, should different allelic variations
of the gene be associated with PTSD, the ﬁndings have
biological plausibility and are less likely to be viewed
as spurious.
However, it is often difﬁcult to identify one or just a
few genes that might be related to a complex behavior,
neural circuit, or functionalsystem, even if that system
is known to be altered in a condition. Indeed, as noted
above,one of the most well-developedareas of biolog-
ical inquiry of PTSD risk is the study of cortisol and
the HPA axis. The HPA axis is the major constituent
of the neuroendocrine response to acute and chronic
stress. In response to stress, the parvocellular neurons
of the hypothalamus are stimulated to secrete the neu-
ropeptidescorticotropinreleasing hormone(CRH) and
vasopressin (AVP) into the portal vessels system to ac-
tivate the synthesis and release of adrenocorticotropic
hormone (ACTH) from the anterior pituitary. ACTH
stimulates the adrenal cortex to synthesize and release
gluccocorticoirds (GCs), in particular cortisol. These
hormones have a multiplicity of functions, which are
necessary for the adaptation to stress [15]. In PTSD
the ﬁne-tuned regulation of this HPA axis is disturbed,
which is indicated by reduced cortisol levels, but also
by an impaired responsiveness of ACTH and cortisol
in these patients (see [16] for a review). What makes
the study of HPA-axis related genes in PTSD so com-
pelling is that in several prospective,longitudinal stud-
ies, lower cortisol levels in the acute aftermath of trau-
ma were associated with either the subsequent devel-
opment of PTSD, or with the well-established risk fac-
tor of prior trauma exposure, and were not necessarily70 R. Yehuda et al. / The role of genes in deﬁning a molecular biology of PTSD
associated with posttraumatic PTSD pathophysiology
per se [17]. These ﬁndings led to the hypothesis that
reducedcortisollevelsatthetimeofatraumamaycom-
promise the inhibition of stress-induced biologic re-
sponses (e.g., during and following a traumatic event),
resulting in a prolonged physiological/emotional dis-
tress which would then facilitate the development of
PTSD[2]. Thatcortisollevelsareassociatedwithsome
aspect of pre-exposure vulnerability provides a plausi-
ble explanation for discrepant observations in PTSD.
That is, it may be that cortisol levels are low only in
PTSD associated with speciﬁc pre-exposure risk fac-
tors, justifying the examination of cortisol function-
ing in association with PTSD risk [6]. This reasoning
has led to several studies examining gene variants in
the CRH gene [18], the glucocorticoid receptor (GR)
gene [19], and in FKBP5 [20,21], a gene which regu-
lates cortisol-bindingafﬁnity and nuclear translocation
of GRs. Because the dopaminergicand adrenergicsys-
temsarealsoimplicatedinstressandfearbiology,vari-
ation in dopamine regulating genes (e.g., dopamine β-
hydroxylase, dopamine transporter and DRD2 genes)
has been investigated in association with PTSD [22–
28]. Variation in the serotonin transporter gene has
been widely studied in association with PTSD [29–31]
and in particular in the context of gene by environment
studies[32–34](seebelowforfurtherdiscussionofthis
type of design). The interested reader is referred to
recent reviews of genetic association studies in PTSD
for further details [35,36].
Investigating the potential upstream effects of
cortisol-related alterations is difﬁcult in practice as
there are thousands of genes that relate in some man-
ner to the regulation of glucocorticoids and their ac-
tions (in endocrine regulation, stress, cognition, etc.).
Thus, even though it would be possible to hypothesize
in a broad sense that genes that modulatethe actions of
glucocorticoids will confer risk for PTSD, a candidate
geneapproachisnotpractical. Atthepresenttime,giv-
en the cost associated with surveying the almost entire
genome in a case where several hundred or thousand
genesmightbecandidates,itwouldbeexpedienttouse
a genome-wide approach.
The genome wide genotyping approach can be con-
trasted to the candidate gene approachin that it is a hy-
pothesisgeneratingmethodthatallowsidentiﬁcationof
a broad set of relevant biological processes that might
otherwise not come into consideration using a candi-
date gene approach. This comprehensive scan of the
genome providesthe opportunityto identify novel sus-
ceptibility factors for the development and persistence
of this disorder. It allows the investigatorto not restrict
the prediction of a gene of interest to the biology that
is known today, but rather aids in the identiﬁcation of
yet unknown mechanisms.
Because of the large number of loci surveyed in a
genome-wide analysis, large sample sizes are required
for such studies. Even with large samples, spurious
ﬁndings are likely to occur based on individual sam-
pling characteristics. For this reason, it is appropriate
to follow up initial observations from a genome-wide
analysiswithareplicationsampletovalidatetheresults
obtained. A genome-wide analysis is also best com-
bined with an evaluation of functional measures with
knownorputativeassociationstoPTSDandPTSDvul-
nerability in order to examine the biological implica-
tions of detected genetic markers for PTSD.
One of the true advantages of examining heritable
genetic variationis that informationabout DNA can be
obtained from any biological sample. Furthermore, it
is not necessary to be concernedwith the time at which
the sample is obtained relative to either the trauma ex-
posure or the development of PTSD. This is not true
for studies of epigenetics or gene expression studies
that are further described below. Indeed, whereas the
examinationofmostmarkersofvulnerabilityforPTSD
might be susceptible to changes by the environment,
genotype is a historical variable that precedes trauma
exposure and will remain unaffected by the exposure.
Howeverwithoutadditionalinformationaboutbothen-
vironmental exposures and other molecular character-
istics, it is not possible to ascertain whether the pres-
ence of a certain genotype has any functional signiﬁ-
cance. For this reason, genes that are identiﬁed based
on a genome wide analysis should be further exam-
ined for differences in DNA methylation that may be
programmed by environmental impact via epigenetic
mechanisms and gene expression. In this way, it is
possibletodeterminewhetheragenevariantassociated
with PTSD or PTSD risk is also associated with PTSD
risk or pathophysiology.
4. Genes and environment jointly predict PTSD
A variant of genotyping studies that is particularly
relevant to PTSD is the genotype-environmentinterac-
tion (GxE) design. This variant is applicable in studies
where the prediction of PTSD is being made in large
samples that are not chosen on the basis of trauma ex-
posure. In the type of study described above, in which
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similarly exposed persons without PTSD, the GxE de-
sign may be less relevant. However, because PTSD
only develops in the context of a traumatic event, it
is probably never appropriate to examine only genetic
maineffects. GxEanalysesarepremisedonthehypoth-
esis that the association between a genetic variant and
PTSD may depend on characteristics of the ‘environ-
ment’(i.e.,thetraumaexposure)includingsuchfactors
as type, level or severityof this exposure. In such anal-
yses, variability in trauma characteristics is not treated
asacovariate,butratherasamoderatorwhichhelpsde-
ﬁne the environmental exposure. In case-control stud-
ies where trauma survivors with PTSD are compared
with those withoutPTSD, the inﬂuenceof priortrauma
exposuremightverywellbetreatedasacovariate,even
thougharguably,cumulativetraumaexposuremightal-
so be conceptualized as an environmental factor (i.e.,
an environmental main effect). Indeed, exposure to
trauma is not binary. Not only are levels of severity
important with respect to a focal trauma, but cumula-
tive effects of a lifetime of experiences. For example,
whether the low expression allele in the promoter re-
gionoftheserotonintransportergeneisassociatedwith
risk of PTSD depends on both individual-level trauma
exposure severity [30] and macro-social context [33].
The possibility of observing a GxE interaction is
complicated by the presence of GxE correlations,
whereby genetic factors associated with PTSD may
also be associated with risk of exposure to the trau-
matic event that is presumed to be the antecedent for
PTSD [37,38]. Indeed, in classic GxE studies there
is an unstated assumption that genotype and the envi-
ronment – in this case trauma exposure – are indepen-
dent. However,extantevidencefrombehavioralgenet-
ics studies clearly demonstrates that the environment
shows genetic inﬂuence: the so-called nature of nur-
ture [39,40]. A recent systematic review by Kendler
andBaker[41]concluded: “Geneticinﬂuencesonmea-
sures of the environment are pervasive in extent and
modest to moderate in impact. These ﬁndings large-
ly reﬂect ’actual behavior’ rather than ’only percep-
tions’. Etiologic models for psychiatric illness need to
account for the non-trivialinﬂuences of genetic factors
on environmental experiences.”
Indeed, if genes predict trauma exposure, then they
do not necessarily interact with such events to produce
a speciﬁc response. As mentioned above, twin studies
have demonstrated that genetic factors inﬂuence expo-
sure to potentially-traumaticevents such as combat ex-
posure [42] and assaultive violence [10]. These genet-
ic effects appear to operate through personality traits.
Longitudinal investigations have found that childhood
emotionaladjustmentandneuroticismpredictedsubse-
quentexposuretostressfullifeeventsinadulthood[43].
Similarly,researchhasfoundthatchildhoodexternaliz-
ingis prospectivelyassociated with bothrisk of trauma
exposure and with PTSD in adulthood [44,45]. These
ﬁndingssuggestgene-environmentcorrelationfortrau-
ma may occur via an individual’s personality, whereby
personality characteristics inﬂuence selection of his or
her environment. Innovative work that aims to over-
come this limitation has focused on traumatic events,
such as large-scale disasters, whose consequences are
more likely to be randomly distributed across popula-
tions [46,47]. Because this approach may not be able
to adequately capture PTSD cases that are the result
of an individual’s participation in the trauma exposure
(e.g., perpetration of violence or participation in com-
bat), it is necessary to use a multi-pronged approach
that includes clinical or other convenience samples in
additiontopopulation-basedsamples. Whereasputting
oneself in a dangerous situation that increases the pos-
sibility of exposure to violence may arguably have a
genetic determinant, exposure to some events that are
traumatic (e.g., the collapse of the World Trade Cen-
ter) are more random. Thus explicitly comparing sub-
populations based on trauma exposure can inform this
issue.
Even more challenging for genotype-environment
interaction studies of PTSD is the possibility of ge-
netic inﬂuences on exposure to early life stress (e.g.
childhood sexual abuse, physical abuse, and neglect).
Childhood traumatization, particularly maltreatment,
does not appear in a vacuum, but rather, in a social
context that often provides fertile ground for parental
abuse or neglect. Parental neglect, for example, may
be a particularly strong risk factor for victimization by
persons outside of the immediate family. Thus, the
presence of speciﬁc gene variants might increase risk
for environmental exposures through the behavior of
caretakers [41,48].
This is important because an association between
an environment – childhood maltreatment- and an out-
come – PTSD- may arise due to a third variable, name-
ly common genetic liability. This genetic third vari-
able confound was described in detail by DiLalla &
Gottesman [49], in responding to the current wisdom
regarding the role of child abuse in the intergenera-
tional transmission of violence [50,51]. In the speciﬁc
example they critiqued, they noted that children who
are abused may also have increased genetic risk for an-
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to abuse their children and antisocial behavior is heri-
table. As such, the environment does not mediate the
associationbetweenchildhoodabuseandantisocialbe-
havior. Whether or not an association is environmen-
tally mediated in this manner might be important for
informing intervention efforts. For example, if the as-
sociation between child abuse and antisocial behavior
is environmentally mediated, then interventions aimed
at preventing child abuse may also prevent antisocial
behavior. If the association is due to a genetic third
variable, then preventing abuse, although clearly im-
portant for its own sake, may well have no impact on
risk for antisocial behavior.
5. Environment modiﬁes gene expression
Implicit in studies of genotype in the context of
PTSD is that genes may interact with the environment
to produce a certain response. However, what has
emergedasanevenmoresalientconceptistheideathat
the environment modiﬁes the way genes function [52].
Interestingly, trauma survivors often speak of being
“transformed” by watershed life events. The study of
how the environmentcan modify gene expression may
therefore provide a biological correlate of this clinical
phenomenon.
Environments do not modify genotype, but they can
affect the way genes function in an enduring manner
throughepigeneticmechanisms(seebelowfordescrip-
tion) and this can be measured in the way genes are
expressed. Because gene expression can be altered by
molecular mechanisms that are not epigenetic, the as-
sessmentofgeneexpressionmaynotnecessarilyimpli-
cate epigenetics. However,a relevant epigenetic modi-
ﬁcation should alter gene expression. Thus examining
epigeneticmechanismsintandemwithgeneexpression
can help identify novel mechanisms mediated by the
environment. Moreover,since genotypemay preferen-
tially inﬂuence the extent of epigenetic or gene expres-
sionchangesresultingfromtheenvironment,optimally
the identiﬁcation of epigenetic changes or alterations
in gene expression should be followed up by studies of
genotype.
6. Environmental exposures can result in
epigenetic alterations
Epigenetics refers to a transgenerationally transmis-
siblefunctionalchangeinthegenomethatcanbedueto
environmentaleventsanddoesnotinvolveanalteration
of sequence [53,54]. Although multiple types of epi-
genetic modiﬁcations have been identiﬁed, all involve
chemical modiﬁcations that regulate chromatin struc-
ture and/or DNA accessibility, which in turn alters the
transcriptionalactivity of the surroundingloci. Methy-
lation – the covalent modiﬁcation of DNA in which
methyl groups are coupled to cytosine at CpG sites –
is perhaps the best studied of these epigenetic mecha-
nisms, due in part to its tractability to study [55–57].
Methylation involves chemical modiﬁcations that reg-
ulate DNA accessibility, which in turn alters the tran-
scriptional activity of the surrounding loci. In many
cases, increased methylation in speciﬁc gene regions
(e.g. promoter) is associated with reduced transcrip-
tional activity and, therefore, lower gene expression.
Because PTSD is inﬂuenced by environmental factors
that predate exposure to a focal traumatic event, epi-
genetic mechanisms may be highly relevant. There is
goodevidenceintheanimalliteraturethatDNAmethy-
lation is a mechanism operative in programming the
activity of genes regulating HPA activity by early life
events (i.e., differences in maternal care) [57–62] that
parallel observations that early life events are associat-
edbothwiththedevelopmentofPTSDandtheHPAax-
is alterations describedin this condition[63–69]. Such
changes result in permanent changes in hippocampal
GR expression and HPA function and provide a clear
molecular link between early environment and gene
expression and function.
Thoughthe similarities between effects of ‘positive’
maternal behaviors in rat pups (i.e., increased licking
and grooming)and PTSD risk are not immediately ob-
vious, they share in common the possibility of deﬁn-
ing the pathways by which environmental risk factors
might directly alter GR expression, thus forming a ba-
sisforindividualdifferencesinendocrinefunctionand,
perhaps, vulnerability. In theory, different cells and
tissues are particularly sensitive to changes in methy-
lation at different times during development,though in
someinstances,suchasthedevelopmentofcancer[70],
DNA methylation appears to be central for the process
throughout life. This is congruent with ﬁndings of a
greaterprevalenceofPTSD followingeventsoccurring
at speciﬁc developmental stages, though this disorder
can develop throughout life [3,4].
Recentworksuggestsspeciﬁcepigeneticpatternsare
associated with PTSD [71]. Speciﬁcally, microarray-
basedmethylationproﬁlesamongindividualswithlife-
time PTSD were characterized by a preponderance of
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gene sets. Further corroboration of these ﬁndings was
provided by the demonstration of signiﬁcantly high-
er levels of antibodies to Cytomegalovirus, a typically
latent herpes virus, in the PTSD affected group. Im-
portantly, this signature of apparent immune dysregu-
lation was also observed in pathways associated with
genes showing a signiﬁcant negative correlation be-
tweenmethylationlevelandnumberoftraumaticevents
experienced by those with lifetime PTSD, suggesting
the possibility that cumulative traumatic burden may
leave a molecular footprint among those with the dis-
order.
7. Environment modiﬁes gene expression [E
changes G]
The interest in candidate gene association and epi-
geneticstudiesis premisedonthe hypothesisthat DNA
sequence variation and methylation differences are as-
sociated with downstream differences in gene expres-
sion. Geneexpressionistheprocessbywhichinforma-
tion from DNA sequence is used in the synthesis of a
functionalgene product. Gene expressionis the funda-
mentalprocessbywhichgenotypegivesrisetothephe-
notype. Microarray based gene-expression analysis is
a method by which the expression level of a very large
numberofgenescanbeevaluated. Theexpressionlevel
of genes is controlled by genetic determinants, epige-
netic modiﬁcations, hormonal inﬂuences, and environ-
mentalfactors. Themicroarraytechniqueoffersthead-
vantage of providing an unbiased survey of the mRNA
expression level of nearly the entire human genome,
allowing the simultaneous analysis of molecular bio-
logical pathways (e.g., genes regulating the expression
of GR receptors and the downstream consequences of
this regulation) that would otherwise be prohibitively
resourceintensive,andidentifyingbiologicalprocesses
involved in disease that were otherwise unsuspected.
Asmallbutgrowingliteraturehasprovidedevidence
for actual changes in gene expression patterns among
PTSD-affectedindividuals. Themajorityofthesestud-
ies have assessed gene expression changes in RNA de-
rived from either peripheral blood mononuclear cells
(PBMCs) or whole blood. Most recently, Yehuda and
colleagues [72] reported whole blood-derivedgene ex-
pression levels amongPTSD-affectedand – unaffected
individualswho had had exposureto the 9/11attack on
NewYorkCity. Differentialexpressionwasdetectedin
16 distinct genes, several of which are involved in sig-
nal transduction, brain and immune cell function and
HPA axis activity, including FKBP5 and signal trans-
ducer and activator of transcription 5B (STAT5B), both
of which were signiﬁcantly down-regulated in PTSD-
affectedindividuals. Asnotedabove,FKBP5actsasan
inhibitor of the glucocorticoid receptor (GR) [73] and
STAT5B has been shown to delay GR nuclear translo-
cation [74]. The detection of decreased expression in
these genes is thus consistent with previous reports of
higher GR activity in PTSD [75–78].
8. Conclusion
Genetic background may contribute to whether one
is exposed to trauma and may interact with environ-
mental exposures, but DNA function can also be mod-
iﬁed by such exposure to these events through epige-
netic pathways, resulting in alterations in gene expres-
sion. In this paper, we have argued that the combined
contribution of all these factors determine susceptibil-
ity versus resilience to development of PTSD. Addi-
tionally, although biological theories of stress and fear
conditioning have guided much of the research focus
on the molecular biology of PTSD, it is important to
broadenour conceptualizationsof the response to trau-
ma. Thereare still manyunansweredquestions regard-
ing the extent to which genes and environmental con-
texts inﬂuence one another but the availability of new
molecular techniques, sampling strategies, and sophis-
ticated statistical methods ensures an almost unlimited
playing ﬁeld for the study of the relative contributions
of genetic and environmental factors in PTSD.
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